Alison Rand
Analyst · William Blair
Thank you, Glenn, and good morning, everyone. Starting with our Term Life segment on slide seven. Operating revenues of $382 million increased 17% year-over-year, and pre-tax operating income of $88 million was 6%. COVID continues to impact results with strong demand for protection products, driving sales growth and policy persistency. The significant level of death claims this quarter more than offset these benefits with the term life margin declining to 17.4% in the quarter from 19% in the prior year period. COVID did not have a significant impact on Term Life results in the first quarter of 2020. As Glenn noted earlier, sales growth continued at double-digit pace. The compounding of sales growth and strong policy retention over the last year moved adjusted direct premium growth to 16% year-over-year and added $9 million to pre-tax income during the quarter. Looking more closely at persistency, we continue to see strong policy retention and aggregate lapse rates about 20% lower year-over-year. First duration persistency saw lower year-over-year increases than other durations, partially due to the strong first duration persistency we were already experiencing in the first quarter of 2020 prior to the onset of COVID. Other policy durations continue to see very strong persistencies, although not at the unprecedented levels seen in the second half of 2020. We believe persistencies will continue to normalize to more sustainable levels throughout 2020. However, it is difficult to predict the pace at which normalization will occur or where retention levels will ultimately settle. For the first quarter, higher persistency resulted in $12 million lower DAC amortization and $7 million of higher benefit reserve increases for net contribution of $5 million to pre-tax income. Turning next to incremental claims attributable to COVID-related deaths. We recognized approximately $21 million in excess claims net of reinsurance during the first quarter, which is in line with our projections and consistent with previous quarter's experience of $1 million for every 10,000 population deaths. Claims were much higher at the start of the period with half of the deaths occurring in January then declining in February and again in March. Combined, the net impact of COVID on sales, persistency and claims resulted in a $7 million reduction to pre-tax income during the first quarter. Moving to Term Life expenses. Insurance commissions increased year-over-year due to higher nondeferred commissions related to enhanced field incentives to offset the absence of our biannual convention that was postponed to next year. Conversely, the insurance expense ratio remains below its historical average during the quarter at 7% compared to 8.5% in last year's first quarter. Expenses remained unchanged year-over-year due to various COVID-related restrictions that impact in-person meetings and licensing costs, which offset higher costs from normal growth in the business. Looking forward, as more people are vaccinated and infection rates decline, we expect sales levels to moderate, as Glenn described earlier. Adjusted direct premiums are expected to grow around 13% on a full year basis with growth rates tapering as the year progresses. Persistency will continue to normalize as previously discussed. Our best estimate is that persistency levels will continue to come down over the next two quarters and will revert to pre-COVID levels by year-end. This looks like the DAC ratio between 14% and 15% for 2021 with typical seasonality from quarter-to-quarter. We estimate second quarter COVID-related claims at approximately $6 million based on a projection of 60,000 population deaths in the U.S. and Canada. Assuming COVID-related deaths continue to decline, we expect the benefits and claims ratio to revert to its historical range between 58% and 59% later in the year. On a full year basis, we expect the benefits ratio to be between 60% and 61% for 2021. To the extent that COVID threats neutralize at the pace we anticipate, we expect full year term life margins to be in the mid-19% range for 2021. Turning to the ISP segment on slide eight. Operating revenues of $223 million increased 21% and pre-tax income of $63 million was 33%. Sales-based revenues were 21%, while revenue-generating sales growth 26%. Very strong sales of mutual funds drove the year-over-year increase. However, revenue growth lagged sales due to the lower average sales-based commission rate earned on mutual funds relative to our other investment products as well as a higher proportion of large dollar trades, which also have a lower commission rate. Sales-based expenses increased in correlation with the associated revenue. Asset-based revenues increased 24%, in line with the increase in average client asset value. Asset-based commission expense grew at a slightly higher pace than revenues as a result of Canadian segregated funds, which experienced less favorable fund performance during the period compared to our other investment products. Expenses for Canadian segregated funds are captured as insurance, commissions and DAC amortization rather than asset-based commissions. Canadian-segregated fund DAC amortization was lower by approximately $1 million year-over-year as last year's first quarter reflected the period's negative market performance, which had a much larger impact than the slightly unfavorable market performance experienced this quarter. Moving next to our Corporate and Other Distributed Products segment on slide nine. The operating loss increased by $4.6 million over last year's first quarter. On the revenue side, mortgage loan commissions increased $4.7 million, following the program's rollout over the past few quarters. Net investment income in this segment was lower by $3 million due to lower portfolio yields, combined with more net investment income being allocated to the term life segment to support the growth in that business. Benefits and expenses were about $7 million higher year-over-year. Mortgage-related commissions and operating expenses were approximately $3.5 million higher with another $5 million largely due to technology spend, higher employee-related costs and strong ancillary product sales. Partly offsetting these increased expenses was a $1.6 million loss associated with reinsurance allowance on a discontinued line of business recognized in the prior year period. Consolidated insurance and other operating expenses on Slide 10 were $122 million during the first quarter, rising 6% or $7 million year-over-year. Growth in the business, technology spending and employee-related costs increased expenses by about $10 million year-over-year, whereas COVID-related restrictions on in-person expenses, such as licensing and education, meetings and travel and entertainment costs, resulted in expenses being about $5 million lower. For the second quarter, both the current year and the prior year period expenses reflect these restrictions, and we expect these costs to increase as travel restrictions lift during the year. Second quarter insurance and other operating expenses are expected to be $113 million or 13% higher than the prior year period, which is excluding any cost associated with the acquisition of e-TeleQuote. Turning to Slide 11. Our invested assets portfolio remains well diversified across industries and issuers. The unrealized gain at the end of March was $98 million compared to $153 million at the end of December 2020, reflecting the increase in market rates during the quarter. On a consolidated basis, net investment income was about $1 million lower year-over-year. On Slide 12, invested assets and cash at the holding company of $369 million has been building to fund the e-TeleQuote acquisition, which we expect to close July 1. Immediately after closing, we expect holding company invested assets and cash to be around $170 million then growing to a more normal level above $200 million over the next few quarters. As we previously announced, we do not plan to repurchase any shares in 2021. We are confident our strong capital generation will allow us to resume repurchases in 2022 and continue to fund both our business growth and e-TeleQuote's cash needs. We expect e-TeleQuote's cash flows to remain negative through 2026 and be in the negative $40 million to $45 million range annually for the next few years. Primerica Life's estimated risk-based capital ratio was 400% at the end of the first quarter, and we plan to remain around this level for the rest of the year as we continue to fund business growth and pay ordinary dividends to the holding company. With that, operator, I open the line up for questions